TearCare System to Treat Dry Eye Disease
(OLYMPIA Trial)
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Sight Sciences, Inc.
No Placebo Group
Trial Summary
What is the purpose of this trial?
In this study, the TearCare System will be compared with the LipiFlow Thermal Pulsation System in patients with dry eye disease. The objective is to demonstrate that the TearCare System is safe and effective in relieving the signs and symptoms of dry eye disease. NOTE: All sites have been selected for this study. We are not seeking additional sites at this time.
Research Team
Eligibility Criteria
Inclusion Criteria
At least 22
Subject has dry eye symptoms and uses artificial tears/lubricants regularly
Subject has moderate to severe symptoms based on a dry eye questionnaire
See 7 more
Treatment Details
Interventions
- LipiFlow (Device)
- TearCare (Device)
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: TearCareExperimental Treatment1 Intervention
Subjects will have heat applied to the eyelids for 15 minutes followed by manual expression of the meibomian glands.
Group II: LipiFlowActive Control1 Intervention
Subjects will have heat and pressure applied to the eyelids for 12 minutes.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sight Sciences, Inc.
Lead Sponsor
Trials
14
Recruited
1,000+